Lv1
100 积分 2022-12-06 加入
A phase 2, adaptive randomized, double-blind, placebo-controlled, multicenter, 52-week study of HM15211 in patients with biopsy-confirmed non-alcoholic steatohepatitis – Study design and rationale of HM-TRIA-201 study
1年前
已完结
Diagnostic biomarkers in Alzheimer’s disease
1年前
已完结
Diagnostic biomarkers in Alzheimer’s disease
1年前
已完结
中国阿尔茨海默病痴呆诊疗指南(2020年版)
1年前
已完结
Caffeine as an analgesic adjuvant. A double-blind study comparing aspirin with caffeine to aspirin and placebo in patients with sore throat
1年前
已完结
Emerging diagnostics and therapeutics for Alzheimer disease
1年前
已完结
Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial
1年前
已完结
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
1年前
已完结
An overview of chemotoxicity and radiation toxicity in cancer therapy
1年前
已完结
Impact of Psychosocial Profile on Alopecia Areata in Pediatric Patients: A Case Control Study from A Tertiary Care Hospital in Eastern Uttar Pradesh
1年前
已完结
皖公网安备34019202002308
